RPRX - CIK 0001802768
Royalty Pharma plc has filed 588 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (283 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-21 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-20 | - |
| Insider trade | 4 | 2026-05-15 | 2026-05-14 |
| Insider trade | 4 | 2026-05-15 | 2026-05-14 |
| Insider sale notice | 144 | 2026-05-14 | - |
| Insider sale notice | 144 | 2026-05-14 | - |
| 13F-NT | - | 2026-05-14 | 2026-03-31 |
| SCHEDULE 13G/A | - | 2026-05-14 | - |
| Insider trade | 4 | 2026-05-08 | 2026-05-06 |
| Insider trade | 4 | 2026-05-08 | 2026-05-06 |
| Insider trade | 4 | 2026-05-08 | 2026-05-06 |
| Insider trade | 4 | 2026-05-08 | 2026-05-06 |
| Quarterly report | 10-Q | 2026-05-06 | 2026-03-31 |
| Major company event | 8-K | 2026-05-06 | 2026-05-06 |
| Insider trade | 4 | 2026-04-30 | 2026-04-28 |
| Insider sale notice | 144 | 2026-04-28 | - |
| Major company event | 8-K | 2026-04-13 | 2026-04-13 |
| Annual report to shareholders | ARS | 2026-04-10 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-10 | - |
| Proxy statement | DEF 14A | 2026-04-10 | 2026-06-04 |
| Insider trade | 4 | 2026-04-02 | 2026-04-01 |
| Insider sale notice | 144 | 2026-04-01 | - |
| 13F-NT | - | 2026-04-01 | 2025-12-31 |
| Insider trade | 4 | 2026-03-31 | 2026-03-31 |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| Insider sale notice | 144 | 2026-03-23 | - |
| Insider sale notice | 144 | 2026-03-19 | - |
| Insider sale notice | 144 | 2026-03-18 | - |
| Insider sale notice | 144 | 2026-03-04 | - |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider sale notice | 144 | 2026-03-02 | - |
| Insider trade | 4 | 2026-02-25 | 2026-02-23 |
| Insider sale notice | 144 | 2026-02-23 | - |
| SCHEDULE 13D/A | - | 2026-02-20 | - |
| Insider trade | 4 | 2026-02-13 | 2026-02-11 |
| Insider trade | 4 | 2026-02-13 | 2026-02-11 |
| Insider trade | 4 | 2026-02-13 | 2026-02-11 |
| SCHEDULE 13G/A | - | 2026-02-13 | - |
| Insider trade | 4 | 2026-02-13 | 2026-02-11 |
| Annual report | 10-K | 2026-02-11 | 2025-12-31 |
| Major company event | 8-K | 2026-02-11 | 2026-02-11 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider sale notice | 144 | 2026-02-03 | - |
| Insider sale notice | 144 | 2026-02-02 | - |
| Insider trade | 4 | 2026-02-02 | 2026-01-30 |
| Insider trade | 4 | 2026-01-26 | 2026-01-23 |
| Insider trade | 4 | 2026-01-23 | 2026-01-20 |
| Insider sale notice | 144 | 2026-01-20 | - |
| Insider trade | 4 | 2026-01-20 | 2026-01-16 |
| Insider trade | 4 | 2026-01-13 | 2026-01-09 |